Letter/Comment

The latest advocacy letters and comments from the American Hospital Association.

AHA again urge the Center for Medicare & Medicaid Innovation to delay the start date for its new radiation oncology alternative payment model until Jan. 1, 2022.
AHA urges CMMI to reconsider sudden changes to the Bundled Payments for Care Improvement Advanced model effective Jan. 1, especially the move to clinical episode service line groups.
AHA comments on the Health Resources and Services Administration’s proposal to add additional counties – specifically, outlying Metropolitan Statistical Area (MSA) counties with no Urbanized Area (UA) – to its list of areas eligible to receive services funded by Federal Office of Rural Health…
AHA follows up on our previous correspondence on the serious situation Eli Lilly, AstraZeneca and Sanofi are creating for the nation’s most vulnerable communities by refusing to comply with the requirements of the 340B program to sell to contract pharmacies at the discounts required by section 340B…
As organizations representing nearly 5,000 hospitals and health systems, more than 1 million physicians, and more than 4 million registered nurses, we call on the Trump Administration to rescind Executive Order 13950, Combating Race and Sex Stereotyping. Each of the actions outlined in EO 13950…
The AHA appreciates the opportunity to comment on the Centers for Medicare & Medicaid Services Healthcare-Associated Infections (HAIs) Requiring Hospitalizations Measure.
The AHA joined five other national medical groups in urging the Department of Homeland Security to exclude foreign national physicians in the J-1 visa program from a proposed change to the process for extending certain non-immigrant visa stays in the United States.
AHA comments on the Centers for Medicare & Medicaid Services’ hospital outpatient prospective payment system and ambulatory surgical center payment system proposed rule for calendar year 2020.
AHA's comments on the Centers for Medicare & Medicaid Services’ proposed rule regarding treatment of Medicare Advantage (MA)/Medicare Part C data in calculating a hospital’s disproportionate patient percentage (DPP) for fiscal years preceding fiscal year (FY) 2014.